Delivery Order SPE2DB20D2014-SPE2DB24FB55D
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Trulicity 3 mg/0.5 ml pen 0.5 ml. The contract has a ceiling value of $12,136.08 and a period of performance through April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Trulicity 3 mg/0.5 ml pens. The $11,704.32 contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp is the prime contractor and this delivery order is issued under an indefinite delivery contract (IDC) awarded solely to the company by DLA, with a potential value of up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Trulicity 3 mg/0.5 ml pens. The $15,840.79 contract has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp serves as the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC allows...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the medication Trulicity 1.5 mg/0.5 ml pen in 0.5 ml doses. The contract has a ceiling value of $2,902.80 and a completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 3 mg/0.5 ml Trulicity pens. The $1,575.90 award has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Trulicity 3 mg/0.5 ml pen 0.5 ml. The contract has a ceiling value of $4,457.68 and a period of performance through April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with a...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Trulicity 0.75 mg/0.5 ml pens. The order has a potential value of $6,281.36 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation, to provide Trulicity 0.75 mg/0.5 ml pens. The $3,612.14 contract has an ultimate completion date of April 5, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 3 mg/0.5 ml Trulicity pharmaceutical pens. The award, valued at $3,269.98, has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds a larger indefinite delivery contract with DLA valued up to $999,999,999.00 through December 2025 to provide a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,198,730 units of the medication Trulicity 1.5 mg/0.5 ml pen. The contract, valued at $3,047.94, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical products to DLA Troop Support Medical facilities in support of...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB55DDelivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product Trulicity 3 mg/0.5 ml pen 0.5ml. The firm fixed price contract has a ceiling value of $1,925.27 and a period of performance through April 9, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 4/8/24 |